Cramer Gives His Opinion On Service Corporation, Vertex And More


On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp INSG acts. He is beginning to believe it deserves to be trading 45% lower.

Biohaven Pharmaceutical Holding Co Ltd BHVN is instrumental, said Cramer. He likes its drug Nurtec.

Cramer is not a buyer of Service Corporation International SCI. He said there are ways to make COVID-19 less life-threatening than the last year.

Cramer is astonished at how much Vertex Pharmaceuticals VRTX has fallen given its cystic fibrosis franchise. He wouldn't sell it at its current price.

Market News and Data brought to you by Benzinga APIs
Posted In: Small CapMediaCNBCJim Cramermad money Lightning Round
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!